Back to Products
VALGOCEL - Valganciclovir

Product Details

Pack Size4x10 Tablets
FormTablets
Therapy AreaRenal Medicine - Transplant
CategoryNephrology · Renal Medicine
Nephrology · Renal Medicine

VALGOCEL

Valganciclovir

Antiviral for CMV prevention in transplant patients

Indication

Prevention and treatment of cytomegalovirus (CMV) infection in kidney and heart transplant recipients at high risk.

Mode of Action

Prodrug of ganciclovir that inhibits CMV DNA polymerase, preventing viral replication. Better oral bioavailability than ganciclovir.

Dosage & Administration

As recommended or prescribed by a healthcare professional, nephrologist, transplant physician, or relevant specialist.

This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.